| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Nurix Therapeutics, Inc. (NRIX) have been net sellers, shedding 49,260 shares worth roughly $1.2M on balance. In the past 30 days, 0 insiders bought and 4 sold.
All 4 insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 123.5K | $3.19M | -6,861 | |
| CFO | 47.5K | $1.23M | -2,834 | |
| Other | 15.3K | $395.9K | -3,957 | |
| Dir | 10.8K | $277.6K | -22,583 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2025 | Christine Ring75 | Chief Legal Officer | Sale+OE | 3,841 | $12.01 | $46,134.25 | -8.0% | +0.2% | - | |
| Jul 30, 2025 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 4,308 | $12.01 | $51,743.39 | -5.9% | +0.2% | - | |
| May 2, 2025 | Hans van Houte56 | Chief Financial Officer | Sell10b5-1 | 6,198 | $11.33 | $70,242.55 | -15.5% | -0.1% | - | |
| Apr 30, 2025 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 3,377 | $11.50 | $38,841.24 | -5.2% | +3.1% | +44.8% | |
| Apr 30, 2025 | Christine Ring75 | Chief Legal Officer | Sale+OE | 2,894 | $11.50 | $33,285.92 | -7.2% | +3.1% | +44.8% | |
| Apr 30, 2025 | Hans van Houte56 | Chief Financial Officer | Sale+OE | 2,438 | $11.50 | $28,041.14 | -5.8% | +3.1% | +44.8% | |
| Mar 3, 2025 | Hans van Houte56 | Chief Financial Officer | Sell10b5-1 | 5,825 | $14.49 | $84,387.72 | -14.7% | -14.4% | +11.5% | |
| Jan 31, 2025 | Christine Ring75 | Chief Legal Officer | Sale+OE10b5-1 | 5,760 | $19.95 | $114,933.87 | -15.0% | -43.4% | -16.2% | |
| Jan 30, 2025 | Christine Ring75 | Chief Legal Officer | Sale+OE | 3,220 | $19.85 | $63,928.87 | -9.0% | -42.4% | -17.5% | |
| Jan 30, 2025 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 3,690 | $19.85 | $73,259.85 | -6.2% | -42.4% | -17.5% |